Clinical Trials

Classical hematologyMyeloidOther hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04256317 2026-04-03

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Phase 2/3 Recruiting

316 enrolled

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT07255872 2026-03-05

A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia

Phase 2/3 Not yet recruiting

216 enrolled

Leukemia, Myeloid, Acute

NCT04817761 2026-02-18

SPARK-ALL: Calaspargase Pegol in Adults With ALL

42 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06378138 2025-11-21

ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)

Phase 2/3 Recruiting

226 enrolled

Phase 2/3 Not yet recruiting

Hematologic Neoplasms

NCT07157514 2025-09-10

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

306 enrolled

Phase 2/3 Active not recruiting

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT04851717 2025-07-01

Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures

100 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03801525 2024-04-19

ULTRA-V

277 enrolled 19 charts

229 enrolled 17 charts 4 FDA

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04145531 2023-11-18

An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Phase 2/3 Completed

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03699475 2023-09-29

THRIVE

MyeloidOther hematologic neoplasm

1 enrolled 9 charts

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00413439 2023-05-10

Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy

Phase 2/3 Completed

18 enrolled

Leukemia, Myeloid, Acute

NCT04021082 2023-02-21

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

Phase 2/3 Withdrawn

Lymphoma, Non-Hodgkin, Leukemia, T-Cell, Lymphoma, T-Cell, Peripheral

NCT02793583 2022-07-21

UNITY-NHL

710 enrolled 2 FDA

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT01518517 2022-02-02

GRASPIVOTALL

Phase 2/3 Completed

85 enrolled 13 charts

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00003338 2021-08-16

Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma

Phase 2/3 Unknown

60 enrolled

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00967343 2021-06-14

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor